[A killed commercial vaccine against herpes simplex viruses 1 and 2 as an immunocorrective agent in chronic herpetic infection].
Barinskiĭ
I F
IF
Ivanovsky Research Institute of Virology, Moscow, Russia.
Kasparov
A A
AA
Lazarenko
A A
AA
Alimbarova
L M
LM
Davydova
A A
AA
Belkina
I V
IV
Platonova
A L
AL
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D002908:Chronic Disease; D006558:Herpes Genitalis / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D006561:Herpes Simplex / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D018259:Herpesvirus 1, Human / Q000276:immunology*; D018258:Herpesvirus 2, Human / Q000276:immunology*; D006801:Humans; D012008:Recurrence; D015164:Vaccines, Inactivated / Q000276:immunology / Q000627:therapeutic use; D014765:Viral Vaccines / Q000276:immunology / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D015164:Vaccines, Inactivated; D014765:Viral Vaccines
Ubitaia kommercheskaia vaktsina protiv virusov prostogo gerpesa 1 i 2 tipov kak sredstvo immunokorrektsii pri khronicheskoĭ gerpeticheskoĭ infektsii.